COLLEEN BROWN: Open Payments
NPI 1902581093 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$726 in 24 payments from 13 companies in 2025. Trend: 2023 $397 · 2024 $969 · 2025 $726
Food & beverage: $726
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $359 |
| Novo Nordisk Inc | 2 | $50 |
| Hologic Sales and Service, LLC | 2 | $47 |
| Exact Sciences Corporation | 2 | $40 |
| ViiV Healthcare Company | 1 | $33 |
| Janssen Pharmaceuticals, Inc | 1 | $29 |
| Gilead Sciences, Inc. | 1 | $29 |
| LEO Pharma Inc. | 1 | $28 |
| PFIZER INC. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $23 |
Products named: BREZTRI, AIRSUPRA, APTIMA, FARXIGA, APRETUDE, Saxenda, SPRAVATO, ANZUPGO.
Industry payments across CA — which companies pay providers there.
